Lipella Pharmaceuticals Inc. (LIPO)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY TTM	FY NaN	FY NaN	FY NaN	FY NaN
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Biopharmaceuticals	449.62K	Log In	Log In	Log In	Log In
Biopharmaceuticals Growth	144.15%	Log In	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY TTM	FY NaN	FY NaN	FY NaN	FY NaN
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
United States	449.62K	Log In	Log In	Log In	Log In
United States Growth	144.15%	Log In	Log In	Log In	Log In